Skip to content
JournalsWorldThe Global Research Discovery Platform

Academic Journal

Q3

Hematology, Transfusion and Cell Therapy

BrazilHematology (Q3); Immunology and Allergy (Q4)ISSN-matched source record
Q3Ranking
—Impact Factor (year unverified)
38H-index (SCImago 2025)
0.37SJR (2025)
2018-2026Coverage

About Hematology, Transfusion and Cell Therapy

Hematology, Transfusion and Cell Therapy is a scholarly journal published by Elsevier Editora Ltda. SCImago 2025 lists it in Q3, with an SJR of 0.37 and H-index of 38.

Coverage: 2018-2026. Research categories: Hematology (Q3); Immunology and Allergy (Q4).

Open-access policies and author information

Reported in the official DOAJ public CSV snapshot (2026-09-01), downloaded 2026-10-03. Record updated 2026-04-27. This snapshot does not establish today’s listing status or fee quotation.

Accepted manuscript languagesEnglish
Licence optionsCC BY
Peer-review processDouble anonymous peer review
APCNo APC reported in the DOAJ snapshot
Waiver policy reportedNo
Other fees reportedNo
Author retains unrestricted copyrightNo
Digital preservationCLOCKSS, PMC, Portico
Reported submission-to-publication time30 weeks on average; not a guarantee
Openly licensed content since2018 (not the journal founding year)

Publisher policy links recorded by DOAJ

Source: DOAJ journal record. Journal metadata is distributed by DOAJ under CC0. Confirm current fees, tax, eligibility and waiver terms with the publisher.

Source-backed journal facts

ISSN(s)2531-1379, 2531-1387
ISSN-L2531-1379
Source typeJournal
Publisher / hosting organisationElsevier BV
Publisher country codeBR
Fully open access (OpenAlex)Yes
DOAJ flag (OpenAlex)Listed in OpenAlex metadata; confirm current status in DOAJ
Works recorded in OpenAlex11,057
Citations recorded in OpenAlex7,447
OpenAlex H-index31
Years represented in OpenAlex1977–2026 (not the founding or closing dates)

Topics in published research

Hemoglobinopathies and Related Disorders; Acute Myeloid Leukemia Research; Blood donation and transfusion practices; Chronic Lymphocytic Leukemia Research; Acute Lymphoblastic Leukemia research; Iron Metabolism and Disorders.

OpenAlex classifies topics from published works. These topics are not the publisher’s official aims and scope.

Source: OpenAlex source record. Retrieved 2026-10-03. Source record updated 2026-10-02. OpenAlex metrics are different from SCImago metrics and the Clarivate Journal Impact Factor.

Found incorrect or outdated information?Help us keep this profile accurate.
Suggest an Edit